Gargling with Gold Nanoparticles Provides a Non-invasive Way to Diagnose Cancer and May Provide Pathologists with a Useful New Clinical Laboratory Test
Researchers at Israel’s Bar-Ilan University attract attention with their unique assay that detects cancers of the tongue and the larynx
Researchers in Israel developed a non-invasive oral test for cancers of the tongue and larynx that uses gold nanoparticles and antibodies to “paint” cancer cells. An imaging tool then allows physicians to identify any tumor cells that may be present.
This demonstration of how the combination of gold nanoparticles and antibodies can detect cancer may form the basis for a new approach that enables in vitro diagnostics manufacturers and pathologists to develop medical laboratory tests that can non-invasively identify different types of cancers.
This nanotechnology-based cancer diagnostic method was created by scientists at Bar-Ilan University (BIU) Ramat Gan, Tel Aviv District of Israel. Researchers conducted successful tests of this technology on animals and “recently proved itself during its first tests on humans,” according to a news story in the Israeli daily Haaretz. (more…)